NCT01093729View on ClinicalTrials.gov

A Study of HM11260C in Healthy Male Subject

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Healthy
Interventions
DRUG

HM11260C

HM11260C 0.5mcg/kg or Placebo

DRUG

HM11260C

HM11260C 2mcg/kg or Placebo

DRUG

HM11260C

HM11260C 4mcg/kg or Placebo

DRUG

HM11260C

HM11260C 8mcg/kg or Placebo

DRUG

HM11260C

HM11260C 14mcg/kg or Placebo

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01093729 - A Study of HM11260C in Healthy Male Subject | Biotech Hunter | Biotech Hunter